A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
Clinical trial NCT01144637 · COMPLETED
Trial details
- NCT number
- NCT01144637
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2013-11-01
- Enrollment
- 4005
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.